» Articles » PMID: 37175655

Potassium Channels, Glucose Metabolism and Glycosylation in Cancer Cells

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 May 13
PMID 37175655
Authors
Affiliations
Soon will be listed here.
Abstract

Potassium channels emerge as one of the crucial groups of proteins that shape the biology of cancer cells. Their involvement in processes like cell growth, migration, or electric signaling, seems obvious. However, the relationship between the function of K+ channels, glucose metabolism, and cancer glycome appears much more intriguing. Among the typical hallmarks of cancer, one can mention the switch to aerobic glycolysis as the most favorable mechanism for glucose metabolism and glycome alterations. This review outlines the interconnections between the expression and activity of potassium channels, carbohydrate metabolism, and altered glycosylation in cancer cells, which have not been broadly discussed in the literature hitherto. Moreover, we propose the potential mediators for the described relations (e.g., enzymes, microRNAs) and the novel promising directions (e.g., glycans-orinented drugs) for further research.

Citing Articles

Blood metal levels predict digestive tract cancer risk using machine learning in a U.S. cohort.

Shi C, Jiang H, Zhao F, Zhang Y, Chen H Sci Rep. 2025; 15(1):1285.

PMID: 39779803 PMC: 11711503. DOI: 10.1038/s41598-025-85659-y.


MAN2B1 in immune system-related diseases, neurodegenerative disorders and cancers: functions beyond α-mannosidosis.

Han Y, Zhou Y, Pan J, Sun M, Yang J Expert Rev Mol Med. 2024; 27():e4.

PMID: 39628046 PMC: 11707832. DOI: 10.1017/erm.2024.34.


Electrical excitability of cancer cells-CELEX model updated.

Djamgoz M Cancer Metastasis Rev. 2024; 43(4):1579-1591.

PMID: 38976181 PMC: 11554705. DOI: 10.1007/s10555-024-10195-6.


The cross-correlation-based analysis to digest the conformational dynamics of the mitoBK channels in terms of their modulation by flavonoids.

Wawrzkiewicz-Jalowiecka A, Trybek P, Dworakowska B, Bednarczyk P, Borys P Eur Biophys J. 2023; 52(6-7):569-582.

PMID: 37389670 PMC: 10618312. DOI: 10.1007/s00249-023-01666-9.

References
1.
Zhang H, Ye W, Li Y . The effect of MiR-497 on the expression of target genes BCL-2 and LC3B on cardiomyocytes injured by hypoxia/reoxygenation. Cell Mol Biol (Noisy-le-grand). 2022; 68(5):170-176. DOI: 10.14715/cmb/2022.68.5.23. View

2.
Tang Y, Zong S, Zeng H, Ruan X, Yao L, Han S . MicroRNAs and angiogenesis: a new era for the management of colorectal cancer. Cancer Cell Int. 2021; 21(1):221. PMC: 8052662. DOI: 10.1186/s12935-021-01920-0. View

3.
Coon J, Kingsley K, Howard K . miR-365 (microRNA): Potential Biomarker in Oral Squamous Cell Carcinoma Exosomes and Extracellular Vesicles. Int J Mol Sci. 2020; 21(15). PMC: 7432426. DOI: 10.3390/ijms21155317. View

4.
Li W, Wilson G, Bachmann M, Wang J, Mattarei A, Paradisi C . Inhibition of a Mitochondrial Potassium Channel in Combination with Gemcitabine and Abraxane Drastically Reduces Pancreatic Ductal Adenocarcinoma in an Immunocompetent Orthotopic Murine Model. Cancers (Basel). 2022; 14(11). PMC: 9179813. DOI: 10.3390/cancers14112618. View

5.
Bauer D, Werth F, Nguyen H, Kiecker F, Eberle J . Critical role of reactive oxygen species (ROS) for synergistic enhancement of apoptosis by vemurafenib and the potassium channel inhibitor TRAM-34 in melanoma cells. Cell Death Dis. 2017; 8(2):e2594. PMC: 5386497. DOI: 10.1038/cddis.2017.6. View